BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 14764897)

  • 21. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
    Lu Y; Zi X; Zhao Y; Pollak M
    Biochem Biophys Res Commun; 2004 Jan; 313(3):709-15. PubMed ID: 14697248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
    Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells.
    Kang NH; Hwang KA; Lee HR; Choi DW; Choi KC
    Food Chem Toxicol; 2013 Sep; 59():373-9. PubMed ID: 23810794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10.
    Dey BR; Frick K; Lopaczynski W; Nissley SP; Furlanetto RW
    Mol Endocrinol; 1996 Jun; 10(6):631-41. PubMed ID: 8776723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Requirements for estrogen receptor alpha membrane localization and function.
    Evinger AJ; Levin ER
    Steroids; 2005; 70(5-7):361-3. PubMed ID: 15862818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly(ADP-ribose) polymerase as a novel regulator of 17β-estradiol-induced cell growth through a control of the estrogen receptor/IGF-1 receptor/PDZK1 axis.
    Kim H; Tarhuni A; Abd Elmageed ZY; Boulares AH
    J Transl Med; 2015 Jul; 13():233. PubMed ID: 26183824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of insulin-like growth factor-1 receptor and IRS-2 signaling by ethanol in SH-SY5Y neuroblastoma cells.
    Seiler AE; Ross BN; Rubin R
    J Neurochem; 2001 Jan; 76(2):573-81. PubMed ID: 11208920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway.
    Kahlert S; Nuedling S; van Eickels M; Vetter H; Meyer R; Grohe C
    J Biol Chem; 2000 Jun; 275(24):18447-53. PubMed ID: 10749889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells.
    Santen RJ; Song RX; Masamura S; Yue W; Fan P; Sogon T; Hayashi S; Nakachi K; Eguchi H
    Adv Exp Med Biol; 2008; 630():19-34. PubMed ID: 18637482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGF-I increases IGFBP-5 and collagen alpha1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells.
    Xin X; Hou YT; Li L; Schmiedlin-Ren P; Christman GM; Cheng HL; Bitar KN; Zimmermann EM
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G777-83. PubMed ID: 15068962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of insulin-like growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation.
    Boney CM; Smith RM; Gruppuso PA
    Endocrinology; 1998 Apr; 139(4):1638-44. PubMed ID: 9528944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
    Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
    Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the insulin-signaling pathway in lacrimal and salivary glands of rats.
    Rocha EM; de M Lima MH; Carvalho CR; Saad MJ; Velloso LA
    Curr Eye Res; 2000 Nov; 21(5):833-42. PubMed ID: 11262604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules.
    Nakamura T; Komiya M; Gotoh N; Koizumi S; Shibuya M; Mori N
    Oncogene; 2002 Jan; 21(1):22-31. PubMed ID: 11791173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro.
    Cosaceanu D; Carapancea M; Alexandru O; Budiu R; Martinsson HS; Starborg M; Vrabete M; Kanter L; Lewensohn R; Dricu A
    Growth Factors; 2007 Feb; 25(1):1-8. PubMed ID: 17454144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of receptor complexes in the extranuclear actions of estrogen receptor alpha in breast cancer.
    Song RX; Fan P; Yue W; Chen Y; Santen RJ
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S3-13. PubMed ID: 17259556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estradiol decreases IGF-1 and IGF-1 receptor expression in rat aortic smooth muscle cells. Mechanisms for its atheroprotective effects.
    Scheidegger KJ; Cenni B; Picard D; Delafontaine P
    J Biol Chem; 2000 Dec; 275(49):38921-8. PubMed ID: 10982795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane association of estrogen receptor alpha mediates estrogen effect on MAPK activation.
    Zhang Z; Maier B; Santen RJ; Song RX
    Biochem Biophys Res Commun; 2002 Jun; 294(5):926-33. PubMed ID: 12074565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells.
    Nolan MK; Jankowska L; Prisco M; Xu S; Guvakova MA; Surmacz E
    Int J Cancer; 1997 Sep; 72(5):828-34. PubMed ID: 9311601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.